Drug Type Small molecule drug |
Synonyms |
Mechanism Mitochondrial complex I (NADH dehydrogenase) inhibitors, SDH2 inhibitors(Mitochondrial complex II; succinate dehydrogenase inhibitors), Glycolysis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | US | 17 May 2019 |